Press "Enter" to skip to content

New patent for Oncopeptides Ab drug PEPAXTO

0
Copyright © DrugPatentWatch. Originally published at New patent for Oncopeptides Ab drug PEPAXTO

Annual Drug Patent Expirations for PEPAXTO
Annual Drug Patent Expirations for PEPAXTO

Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug.

This drug has seventy-six patent family members in twenty-seven countries.

The generic ingredient in PEPAXTO is melphalan flufenamide hydrochloride. Additional details are available on the melphalan flufenamide hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Oncopeptides Ab drug PEPAXTO
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions